Ethical codes on drug promotion in UK and Sweden are too weak, say researchersBMJ 2015; 350 doi: http://dx.doi.org/10.1136/bmj.h917 (Published 18 February 2015) Cite this as: BMJ 2015;350:h917
- Zosia Kmietowicz
- 1The BMJ
The authors of a study that found that the drug industry’s ethical codes on drug promotion in the United Kingdom and Sweden did not match the behaviour of individual companies have called for a raft of tighter measures, including bigger fines, to improve the quality of information the companies produce.
The authors concluded, “Policies that might improve the quality of medicines information include intensified pre-vetting and active monitoring efforts in conjunction with larger fines, as well as greater publicity following rulings.”
For the study the researchers, from Lund University …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial